{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:12:39Z","timestamp":1780337559235,"version":"3.54.1"},"reference-count":137,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/14737140.2021.1903875","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T14:09:00Z","timestamp":1615644540000},"page":"887-900","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy"],"prefix":"10.1080","volume":"21","author":[{"given":"Federica","family":"Zito Marino","sequence":"first","affiliation":[{"name":"University of Campania \u2018Luigi Vanvitelli","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Al\u00ec","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facchinetti","sequence":"additional","affiliation":[{"name":"INSERM, Biomarqueurs pr\u00e9dictifs et nouvelles strat\u00e9gies th\u00e9rapeutiques en oncologie","place":["Villejuif, France"]},{"name":"University Hospital of Parma","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Righi","sequence":"additional","affiliation":[{"name":"University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fontanini","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rossi","sequence":"additional","affiliation":[{"name":"Teaching Hospital S. Maria Delle Croci","place":["Ravenna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-3184","authenticated-orcid":false,"given":"Renato","family":"Franco","sequence":"additional","affiliation":[{"name":"University of Campania \u2018Luigi Vanvitelli","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/359162a0"},{"key":"e_1_3_4_4_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell PC","year":"1960","unstructured":"Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85\u2013109.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.32.1.495"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2019.1625494"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26777"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0135-RA"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3539"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.406"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.050"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.9b00019"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0101"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0258"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103718"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0346-OA"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw302"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.7293"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.02.023"},{"issue":"2","key":"e_1_3_4_21_1","first-page":"70","article-title":"Concordance of IHC, FISH, and RT-PCR for EML4-ALK rearrangements","volume":"3","author":"Teixido C","year":"2014","unstructured":"Teixido C, Karachaliou N, Peg V, et al. Concordance of IHC, FISH, and RT-PCR for EML4-ALK rearrangements. Transl Lung Cancer Res. 2014;3(2):70\u201374.","journal-title":"Transl Lung Cancer Res"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4736-4"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000068"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.7539"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508887"},{"issue":"134","key":"e_1_3_4_26_1","first-page":"57079","article-title":"A blood-based test for the detection of ROS1 and RET fusion transcripts from circulating ribonucleic acid using digital polymerase chain reaction","volume":"2018","author":"Mellert HS","unstructured":"Mellert HS, Alexander KE, Jackson LP, et al. A blood-based test for the detection of ROS1 and RET fusion transcripts from circulating ribonucleic acid using digital polymerase chain reaction. J Vis Exp. 2018;(134):57079.","journal-title":"J Vis Exp"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2683"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05945"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-012-1281-4"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2947"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2017.11.004"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.12.111"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv501"},{"key":"e_1_3_4_34_1","unstructured":"List of cleared or approved companion diagnostic devices (In vitro and imaging tools) [Internet]. [cited 2021 Mar 4]. Available from: www.fda.gov\/medical-devices\/vitro-diagnostics\/list-cleared-or-approved-companion-diagnostic-devices-vitro-and-imaging-tools\/"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.02.008"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-017-0428-0"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0066"},{"key":"e_1_3_4_38_1","unstructured":"FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC [Internet]. [cited 2021 Mar 4]. Available from: https:\/\/www.fda.gov\/drugs\/fda-approves-lorlatinib-second-or-third-line-treatment-alk-positive-metastatic-nsclc"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0408-9"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.08.002"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.43.28065"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108166200"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1492"},{"key":"e_1_3_4_44_1","first-page":"45e55","article-title":"Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives","volume":"8","author":"Rossi G","year":"2017","unstructured":"Rossi G, Jocolle G, Conti A, et al. Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives. Lung Cancer (Auckl). 2017;8:45e55.","journal-title":"Lung Cancer (Auckl)"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-016-2000-3"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2020.04.014"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2019-206152"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23318"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.07.005"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2019-0085-OA"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.06.019"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.03.024"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep42259"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.265314"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2013.11.007"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.041"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0031"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406766"},{"issue":"20","key":"e_1_3_4_59_1","first-page":"39971","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group","volume":"0923","author":"Mosele F","year":"2020","unstructured":"Mosele F, Remon J, Mateo J, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol. 2020;S0923\u20137534(20)39971\u201339973.","journal-title":"Ann Oncol"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz131"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30690-4"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1237"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3701"},{"key":"e_1_3_4_64_1","article-title":"Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small-cell lung cancer","volume":"2017","author":"Gainor JF","year":"2017","unstructured":"Gainor JF, Tseng D, Yoda S, et al. Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small-cell lung cancer. JCO Precis Oncol. 2017;2017:PO.17.00063.","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30655-2"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.9011"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90115-1"},{"issue":"1","key":"e_1_3_4_68_1","first-page":"81","article-title":"Ret protooncogene and human-diseases \u2013 review","volume":"4","author":"Takahashi M","year":"1994","unstructured":"Takahashi M. Ret protooncogene and human-diseases \u2013 review. Int J Oncol. 1994;4:81\u201384. 1","journal-title":"Int J Oncol"},{"key":"e_1_3_4_69_1","first-page":"1519","article-title":"Human ret proto-oncogene mapped to chromosome 10q11.2","volume":"4","author":"Ishizaka Y","year":"1989","unstructured":"Ishizaka Y, Itoh F, Tahira T, et al. Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene. 1989;4:1519\u20131521.","journal-title":"Oncogene"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2658"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.11"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.7.851"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/367375a0"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0484"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.9352"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.175"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.8240"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3680"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2644"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.1477"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0035"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1146-8"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.07.009"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.36"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.10.021"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.08.011"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30562-9"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30322-8"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw559"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6144"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw042"},{"key":"e_1_3_4_92_1","unstructured":"FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions [Internet]. [cited 2021 Mar 4]. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-selpercatinib-lung-and-thyroid-cancers-ret-gene-mutations-or-fusions"},{"key":"e_1_3_4_93_1","unstructured":"FDA approves pralsetinib for lung cancer with RET gene fusions [Internet]. [cited 2021 Mar 4]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pralsetinib-lung-cancer-ret-gene-fusions"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.01.006"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz383"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90223-2"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3352"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0765"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-017-0967-5"},{"key":"e_1_3_4_100_1","first-page":"2018:PO.18.0003","article-title":"Clinicopathologic features of non-small-cell lung cancer harboring an NTRK gene fusion","author":"Farago AF","year":"2018","unstructured":"Farago AF, Taylor MS, Doebele RC, et al. Clinicopathologic features of non-small-cell lung cancer harboring an NTRK gene fusion. JCO Precis Oncol. 2018;2018:PO.18.00037.\u00a0","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02921-6"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0324-7"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000911"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz204"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0507"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29825"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0633"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0284"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0075"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0107"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.07.022"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.05.015"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.09.014"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0160"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.07.026"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0050"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2166"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2017.08.02"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2088-5"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.027"},{"key":"e_1_3_4_121_1","unstructured":"FDA approves first liquid biopsy next-generation sequencing companion diagnostic test [Internet]. [cited 2021 Mar 4]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test\/"},{"key":"e_1_3_4_122_1","unstructured":"FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers [Internet]. [cited 2021 Mar 4]. Available from: https:\/\/www.fda.gov\/drugs\/fda-approves-liquid-biopsy-ngs-companion-diagnostic-test-multiple-cancers-and-biomarkers"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5932"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21835"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4333"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.127"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.08.008"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4305"},{"key":"e_1_3_4_130_1","volume-title":"IASLC Atlas of ALK and ROS1 testing in lung cancer","author":"Tsao MS","year":"2016","unstructured":"Tsao MS, Hirsh FR, Yatabe Y, editors. IASLC Atlas of ALK and ROS1 testing in lung cancer. 2nd ed. Fort Meyers: Editorial Rx Press; 2016.","edition":"2"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S156672"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics6010004"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21919"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205827"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.11.117"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.04.1372"},{"issue":"2","key":"e_1_3_4_137_1","first-page":"1","article-title":"Correlating ROS1 protein expression with ROS1 fusions, amplifications, and mutations","volume":"2","author":"Huang RSP","year":"2021","unstructured":"Huang RSP, Gottberg-Williams A, Vang P, et al. Correlating ROS1 protein expression with ROS1 fusions, amplifications, and mutations. JTO Clin Res Rep 2021;2:1\u20139 2","journal-title":"JTO Clin Res Rep"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.021"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0372"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2021.1903875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:02:01Z","timestamp":1772762521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2021.1903875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/14737140.2021.1903875"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2021.1903875","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}